Review



gdf15  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems gdf15
    Gdf15, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gdf15/product/R&D Systems
    Average 93 stars, based on 15 article reviews
    gdf15 - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress recombinant murine gdf15 protein
    Recombinant Murine Gdf15 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant murine gdf15 protein/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    recombinant murine gdf15 protein - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    R&D Systems gdf15
    Gdf15, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gdf15/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    gdf15 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    PeproTech recombinant human gdf-15 protein
    Recombinant Human Gdf 15 Protein, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human gdf-15 protein/product/PeproTech
    Average 90 stars, based on 1 article reviews
    recombinant human gdf-15 protein - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    PeproTech recombinant gdf-15 protein
    Recombinant Gdf 15 Protein, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant gdf-15 protein/product/PeproTech
    Average 90 stars, based on 1 article reviews
    recombinant gdf-15 protein - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    95
    OriGene rp12738 0 5 gdf 15 r d systems 957 gd cndp2 human recombinant protein origene nm 018235 4 hydroxytamoxifen sigma h6278 exendin 3
    Rp12738 0 5 Gdf 15 R D Systems 957 Gd Cndp2 Human Recombinant Protein Origene Nm 018235 4 Hydroxytamoxifen Sigma H6278 Exendin 3, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rp12738 0 5 gdf 15 r d systems 957 gd cndp2 human recombinant protein origene nm 018235 4 hydroxytamoxifen sigma h6278 exendin 3/product/OriGene
    Average 95 stars, based on 1 article reviews
    rp12738 0 5 gdf 15 r d systems 957 gd cndp2 human recombinant protein origene nm 018235 4 hydroxytamoxifen sigma h6278 exendin 3 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant gdf15 protein
    Recombinant Gdf15 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant gdf15 protein/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    recombinant gdf15 protein - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Boster Bio gdf15
    Characteristics of obesity subjects according to MASLD and MetS
    Gdf15, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gdf15/product/Boster Bio
    Average 93 stars, based on 1 article reviews
    gdf15 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant gdf15 957 gd
    a , b , Change in body weight ( a ) and food intake ( b ) of 26–28-week-old male DIO C57BL/6J mice following 7 days of treatment with the indicated dose of N -acetyltaurine (NAT; i.p.). For saline versus N -acetyltaurine (15 mg per kg per day), P = 5.95 × 10 –4 ; for saline versus N -acetyltaurine (50 mg per kg per day), P = 6.3 × 10 –4 . N = 5 per group for vehicle, 1 and 5 mg per kg per day; N = 6 per group for 15 and 50 mg per kg per day. c , d , Change in body weight ( c ) and food intake ( d ) of 19–21-week-old male DIO C57BL/6J mice following treatment with the indicated metabolite at a dose of 15 mg per kg per day (i.p.). N = 5 per group. e – g , Western blots with anti-PTER (top) and anti-tubulin (bottom) antibodies ( e ), N -acetyltaurine hydrolysis activity ( f ) and tissue N -acetyltaurine levels ( g ) from cortex (Cort.), hypothalamus (Hyp.) and brainstem (BS) of WT mice and Pter KO mice. For WT versus Pter KO brainstem, P = 6.65 × 10 –4 . N = 6 per group for f and g . h , Change in 24-h food intake of 6-month-old male DIO mice treated with a single dose of <t>GDF15</t> (0.1 mg kg –1 , i.p.) in the presence of anti-GFRAL antibody (10 mg kg –1 , i.p.) or IgG control antibody (10 mg kg –1 , i.p.). N = 5 per group. i , j , Change in body weight ( i ) and cumulative food intake ( j ) of 16-week-old male DIO mice following saline or N -acetyltaurine (15 mg per kg per day, i.p.) treatment and with IgG or anti-GFRAL antibody co-treatment (10 mg kg –1 , i.p., once every 3 days). N = 10 per group. Data are shown as the mean ± s.e.m. For e , the loading control was performed on the same blot. In a – d and f – h , P values were calculated from two-tailed unpaired t -tests and were not corrected for multiple comparisons. In i and j , P values were calculated from two-way ANOVA with post hoc Sidak’s multiple comparisons test. All experiments were performed once.
    Recombinant Gdf15 957 Gd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant gdf15 957 gd/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    recombinant gdf15 957 gd - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Characteristics of obesity subjects according to MASLD and MetS

    Journal: Italian Journal of Pediatrics

    Article Title: Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity

    doi: 10.1186/s13052-024-01733-7

    Figure Lengend Snippet: Characteristics of obesity subjects according to MASLD and MetS

    Article Snippet: Serum levels of adiponectin, leptin, GDF15, IGF-1, CES1 were measured using enzyme-linked immunosorbent assay ELESA kits (Boster Biological, Pleasanton, CA) following the manufacturer’s protocol.

    Techniques:

    Correlation analysis between CES1 and obesity-related secreted proteins. ( A ) Adiponectin, ( B ) Leptin, ( C ) GDF15, ( D ) IGF-1. Spearman correlation coefficient was used. Statistical assessment was 2-sided and considered statistically significant at * P < 0.05, ** P < 0.01

    Journal: Italian Journal of Pediatrics

    Article Title: Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity

    doi: 10.1186/s13052-024-01733-7

    Figure Lengend Snippet: Correlation analysis between CES1 and obesity-related secreted proteins. ( A ) Adiponectin, ( B ) Leptin, ( C ) GDF15, ( D ) IGF-1. Spearman correlation coefficient was used. Statistical assessment was 2-sided and considered statistically significant at * P < 0.05, ** P < 0.01

    Article Snippet: Serum levels of adiponectin, leptin, GDF15, IGF-1, CES1 were measured using enzyme-linked immunosorbent assay ELESA kits (Boster Biological, Pleasanton, CA) following the manufacturer’s protocol.

    Techniques:

    a , b , Change in body weight ( a ) and food intake ( b ) of 26–28-week-old male DIO C57BL/6J mice following 7 days of treatment with the indicated dose of N -acetyltaurine (NAT; i.p.). For saline versus N -acetyltaurine (15 mg per kg per day), P = 5.95 × 10 –4 ; for saline versus N -acetyltaurine (50 mg per kg per day), P = 6.3 × 10 –4 . N = 5 per group for vehicle, 1 and 5 mg per kg per day; N = 6 per group for 15 and 50 mg per kg per day. c , d , Change in body weight ( c ) and food intake ( d ) of 19–21-week-old male DIO C57BL/6J mice following treatment with the indicated metabolite at a dose of 15 mg per kg per day (i.p.). N = 5 per group. e – g , Western blots with anti-PTER (top) and anti-tubulin (bottom) antibodies ( e ), N -acetyltaurine hydrolysis activity ( f ) and tissue N -acetyltaurine levels ( g ) from cortex (Cort.), hypothalamus (Hyp.) and brainstem (BS) of WT mice and Pter KO mice. For WT versus Pter KO brainstem, P = 6.65 × 10 –4 . N = 6 per group for f and g . h , Change in 24-h food intake of 6-month-old male DIO mice treated with a single dose of GDF15 (0.1 mg kg –1 , i.p.) in the presence of anti-GFRAL antibody (10 mg kg –1 , i.p.) or IgG control antibody (10 mg kg –1 , i.p.). N = 5 per group. i , j , Change in body weight ( i ) and cumulative food intake ( j ) of 16-week-old male DIO mice following saline or N -acetyltaurine (15 mg per kg per day, i.p.) treatment and with IgG or anti-GFRAL antibody co-treatment (10 mg kg –1 , i.p., once every 3 days). N = 10 per group. Data are shown as the mean ± s.e.m. For e , the loading control was performed on the same blot. In a – d and f – h , P values were calculated from two-tailed unpaired t -tests and were not corrected for multiple comparisons. In i and j , P values were calculated from two-way ANOVA with post hoc Sidak’s multiple comparisons test. All experiments were performed once.

    Journal: Nature

    Article Title: PTER is a N -acetyltaurine hydrolase that regulates feeding and obesity

    doi: 10.1038/s41586-024-07801-6

    Figure Lengend Snippet: a , b , Change in body weight ( a ) and food intake ( b ) of 26–28-week-old male DIO C57BL/6J mice following 7 days of treatment with the indicated dose of N -acetyltaurine (NAT; i.p.). For saline versus N -acetyltaurine (15 mg per kg per day), P = 5.95 × 10 –4 ; for saline versus N -acetyltaurine (50 mg per kg per day), P = 6.3 × 10 –4 . N = 5 per group for vehicle, 1 and 5 mg per kg per day; N = 6 per group for 15 and 50 mg per kg per day. c , d , Change in body weight ( c ) and food intake ( d ) of 19–21-week-old male DIO C57BL/6J mice following treatment with the indicated metabolite at a dose of 15 mg per kg per day (i.p.). N = 5 per group. e – g , Western blots with anti-PTER (top) and anti-tubulin (bottom) antibodies ( e ), N -acetyltaurine hydrolysis activity ( f ) and tissue N -acetyltaurine levels ( g ) from cortex (Cort.), hypothalamus (Hyp.) and brainstem (BS) of WT mice and Pter KO mice. For WT versus Pter KO brainstem, P = 6.65 × 10 –4 . N = 6 per group for f and g . h , Change in 24-h food intake of 6-month-old male DIO mice treated with a single dose of GDF15 (0.1 mg kg –1 , i.p.) in the presence of anti-GFRAL antibody (10 mg kg –1 , i.p.) or IgG control antibody (10 mg kg –1 , i.p.). N = 5 per group. i , j , Change in body weight ( i ) and cumulative food intake ( j ) of 16-week-old male DIO mice following saline or N -acetyltaurine (15 mg per kg per day, i.p.) treatment and with IgG or anti-GFRAL antibody co-treatment (10 mg kg –1 , i.p., once every 3 days). N = 10 per group. Data are shown as the mean ± s.e.m. For e , the loading control was performed on the same blot. In a – d and f – h , P values were calculated from two-tailed unpaired t -tests and were not corrected for multiple comparisons. In i and j , P values were calculated from two-way ANOVA with post hoc Sidak’s multiple comparisons test. All experiments were performed once.

    Article Snippet: Recombinant GDF15 (957-GD) was purchased from R&D Systems.

    Techniques: Saline, Western Blot, Activity Assay, Control, Two Tailed Test

    Related to Fig. . a - d , Body weight ( a , b ) and food intake ( c , d ) of 6 to 7-month-old DIO male C57BL/6J mice after a 7-day treatment of saline or N-acetyltaurine (15 mg/kg/day, IP) or GLP-1 (2 mg/kg/day, IP) with or without Exendin-3 (0.1 mg/kg/day, IP). N = 7/group. NAT, N-acetyltaurine. e , f , Body weight ( e ) and food intake ( f ) of 5-month-old DIO male C57BL/6J mice or 3 to 4-month-old MC4R-KO mice on high fat diet after a 7-day treatment of saline or N-acetyltaurine (15 mg/kg/day, IP). N = 6/group. NAT, N-acetyltaurine. g , Plasma GDF15 (left), GLP-1 (middle) and leptin (right) levels of 19 to 21-week-old male DIO C57BL/6J mice following treatment with N-acetyltaurine 15 mg/kg/day (IP) or saline. N = 5 per group. NAT, N-acetyltaurine. Data are shown as mean ± SEM. P-values were calculated from two-tailed unpaired t-tests.

    Journal: Nature

    Article Title: PTER is a N -acetyltaurine hydrolase that regulates feeding and obesity

    doi: 10.1038/s41586-024-07801-6

    Figure Lengend Snippet: Related to Fig. . a - d , Body weight ( a , b ) and food intake ( c , d ) of 6 to 7-month-old DIO male C57BL/6J mice after a 7-day treatment of saline or N-acetyltaurine (15 mg/kg/day, IP) or GLP-1 (2 mg/kg/day, IP) with or without Exendin-3 (0.1 mg/kg/day, IP). N = 7/group. NAT, N-acetyltaurine. e , f , Body weight ( e ) and food intake ( f ) of 5-month-old DIO male C57BL/6J mice or 3 to 4-month-old MC4R-KO mice on high fat diet after a 7-day treatment of saline or N-acetyltaurine (15 mg/kg/day, IP). N = 6/group. NAT, N-acetyltaurine. g , Plasma GDF15 (left), GLP-1 (middle) and leptin (right) levels of 19 to 21-week-old male DIO C57BL/6J mice following treatment with N-acetyltaurine 15 mg/kg/day (IP) or saline. N = 5 per group. NAT, N-acetyltaurine. Data are shown as mean ± SEM. P-values were calculated from two-tailed unpaired t-tests.

    Article Snippet: Recombinant GDF15 (957-GD) was purchased from R&D Systems.

    Techniques: Saline, Two Tailed Test